Related Experiment Video
Updated: Sep 9, 2025
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Development of Drug-resistant Cell Lines for Experimental Procedures
Suguru Kadomoto1, Greg Shelley2, Atsushi Mizokami3
1Department of Urology, University of Michigan, Ann Arbor; Department of Urology, Kanazawa University.
Abstract:
The development of drug-resistant cell lines is essential for understanding the mechanisms of drug resistance and identifying strategies to overcome treatment failure in cancer therapy. Resistance models enable preclinical evaluation of novel compounds, repurposed drugs, and combination therapies. To generate resistant cells, parental cancer cell lines are repeatedly exposed to incrementally increasing concentrations of the target drug over several weeks. Cells that survive and proliferate at each stage are selected, expanded, and exposed to higher drug doses. The development of resistance is confirmed by quantifying and comparing the half-maximal inhibitory concentration (IC50) values between parental and resistant cells using cell viability assays and nonlinear regression analysis. Significantly increased IC50 values indicate successful adaptation to drug pressure and the development of resistance. These drug-resistant cell lines are available for comprehensive analysis, such as microarray and single-cell sequencing, as well as various in vitro or in vivo experiments. These models provide valuable tools for investigating potential therapeutic strategies to overcome drug resistance.
Insights
Researchers developed drug-resistant cancer cell lines to study resistance mechanisms and test new cancer therapies. These models are crucial for evaluating drug effectiveness and overcoming treatment failure.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Drug resistance is a major challenge in cancer therapy, leading to treatment failure.
- Developing drug-resistant cell lines is crucial for understanding resistance mechanisms.
- These models facilitate preclinical evaluation of novel compounds and combination therapies.
Purpose of the Study:
- To establish and validate drug-resistant cancer cell line models.
- To provide tools for investigating strategies to overcome cancer drug resistance.
- To enable comprehensive analysis of resistance mechanisms.
Main Methods:
- Parental cancer cell lines were exposed to incrementally increasing drug concentrations over several weeks.
- Surviving cells were selected, expanded, and exposed to higher doses to induce resistance.
- Drug resistance was confirmed by comparing half-maximal inhibitory concentration (IC50) values using cell viability assays.
Main Results:
- Significantly increased IC50 values were observed in resistant cell lines compared to parental cells.
- Successful adaptation to drug pressure and development of resistance were confirmed.
- Generated drug-resistant cell lines are available for further molecular and experimental analyses.
Conclusions:
- Drug-resistant cell lines are valuable preclinical models for cancer research.
- These models aid in understanding drug resistance mechanisms and developing therapeutic strategies.
- The established models support the investigation of novel treatments to overcome resistance in cancer therapy.
More Related Videos
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Related Concept Videos
02:56Treatment Resistant Cancers
01:16Cell Lines
01:30Development of Antibiotic Resistance
00:57Antibiotic Selection